Author:
Lin Wen H.,Feng Hwa-Ping,Shadle Craig R.,O’Reilly Terry,Wagner John A.,Butterton Joan R.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference10 articles.
1. Malcolm BA, Liu R, Lahser F, Agrawal S, Belanger B, Butkiewicz N, Chase R, Gheyas F, Hart A, Hesk D, Ingravallo P, Jiang C, Kong R, Lu J, Pichardo J, Prongay A, Skelton A, Tong X, Venkatraman S, Xia E, Girijavallabhan V, Njoroge FG (2006) SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells. Antimicrob Agents Chemother 50:1013–1020
2. Poordad F, McCone J, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy R, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki J-P (2011) Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 364:1195–1206
3. Bacon B, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Burroughs M, Brass CA, Albrecht JK, Esteban R (2011) Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 364:1207–1217
4. Ghosal A, Yuan Y, Tong W, Su A, Gu C, Chowdhury SK, Kishnani NS (2011) Characterization of human liver enzymes involved in the biotransformation of boceprevir, a HCV protease inhibitor. Drug Metab Dispos 39:510–521. doi: 10.1124/dmd.110.036996
5. Chu X, Cai X, Cui D et al (2011) In vitro assessment of drug-drug interaction potential of boceprevir as an inhibitor and inducer of drug metabolizing enzymes and transporters. Hepatology 54(4 suppl):140A
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献